RLY5016 Placebo for Oral Suspension was developed for clinical trials and is intended to be administered orally clinical trials

Double-blind, placebo-controlled clinical trial to determine the effect of Patiromer on vascular function and its relationship with mineral metabolism parameters

This study looks at how a drug called Patiromer affects blood vessel health in people with long-term kidney disease. We want to see if it improves how flexible their arteries are and how it relates to important body chemicals like calcium and phosphate.